ClinicalTrials.gg
CompletedNCT07783776Yintang AcupreUpdated Aug 26, 2026

Yintang Acupressure During Labor in Primiparous Women

An interventional study of Yintang Acupressure and Sham Light Touch in Labor Pain and Anxiety, sponsored by Inonu University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by Inonu University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled Jun 2024, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
104
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 119 studies in Labor Pain with a site in Turkey — 22 open to participants now, 30 under way, none of them phase 3. Labor Pain · Turkey.

Enrollment
46th of 112
104 · median 94
Started
2024
with 19 others
No phase
111 of 119
20 open now
Registered
110th of 119
by date

Among the 119 studies in Labor Pain with a site in Turkey, this one is the 46th largest by enrollment of the 112 interventional ones that give a count, is one of 20 that started in 2024, is one of 111 with no phase, and was the 110th registered.

Labor Pain

423 studies on the registry are indexed under Labor Pain; 74 are open to participants now.

Browse Labor Pain studies →

Open to participants now

22 of the 119 studies in Labor Pain with a site in Turkey are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 30 Labor Pain studies recruiting now, 8 (27%) set no upper age limit and 22 (73%) stop at 75 or younger; 3 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 119 studies in Labor Pain with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled study evaluated whether acupressure applied to the Yintang point during labor affects labor duration, pain, anxiety, and childbirth satisfaction in primiparous women. A total of 104 women were randomly assigned to either the Yintang acupressure group or the sham light-touch control group, with 52 participants in each group.

Participants in the intervention group received five acupressure sessions during labor and the early postpartum period. Participants in the control group received routine midwifery care and light touch at a non-therapeutic forehead location. Labor duration, pain intensity, anxiety, and childbirth satisfaction were compared between the groups.

Read the detailed description

This study was conducted as a randomized, sham-controlled clinical trial involving primiparous women admitted to the maternity ward of a hospital in eastern Türkiye. The study aimed to evaluate the effects of Yintang acupressure on labor duration, labor pain, postpartum anxiety, and childbirth satisfaction.

A total of 104 eligible participants were randomly assigned in a 1:1 ratio to the intervention group (n=52) or the sham control group (n=52). Participants in both groups received routine midwifery care.

Participants assigned to the intervention group received manual acupressure at the Yintang point, located on the midline of the forehead between the eyebrows. Five sessions were administered: at 5-6 cm cervical dilation, at 6-7 cm cervical dilation, at approximately 8 cm cervical dilation, during the third stage of labor, and 60 minutes after childbirth. Each session lasted approximately 6-7 minutes.

Participants in the sham control group received light touch at a forehead location outside the Yintang point. The duration, participant position, and practitioner contact were designed to resemble the intervention procedure without applying therapeutic pressure to the Yintang point.

Labor duration was recorded using a labor monitoring form. Pain intensity was evaluated using the Visual Analogue Scale at prespecified assessment points. Anxiety was assessed using the Beck Anxiety Inventory, and childbirth satisfaction was assessed using the Birth Satisfaction Assessment Form after childbirth.

Because participant recruitment and data collection had been completed before submission of this record, the study was registered retrospectively.

03

Conditions studied

  • Labor Pain
  • Anxiety

Keywords

  • yintang
  • acupressure
  • labor duration
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

  • Primiparous women
  • Aged 18 years or older
  • In the active phase of labor with cervical dilation of 5-6 cm at enrollment
  • Term singleton pregnancy
  • Fetus in cephalic presentation
  • No known fetal congenital anomaly
  • Intact and healthy skin at the forehead area where acupressure or sham light touch will be applied
  • Able and willing to provide written

Exclusion Criteria:

  • Known sensitivity or intolerance to acupressure or touch at the application site
  • Use of pharmacological pain-control methods before enrollment, including analgesics, sedatives, or epidural analgesia
  • High-risk pregnancy, including preeclampsia or diabetes
  • History of a diagnosed neurological or psychiatric disorder
  • Signs of fetal distress
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
104 participants (actual)

Study arms

  • Experimental
    Yintang Acupressure

    Participants received routine midwifery care and manual acupressure at the Yintang point. Five sessions were administered: at 5-6 cm cervical dilation, at 6-7 cm cervical dilation, at approximately 8 cm cervical dilation, during the third stage of labor, and 60 minutes after childbirth. Each session lasted approximately 6-7 minutes.

    Other: Yintang Acupressure

  • Sham comparator
    Sham Light-Touch Control

    Participants received routine midwifery care and light touch at a forehead location outside the Yintang point. The sham procedure was administered at the same assessment periods and for approximately the same duration as the Yintang acupressure intervention, without applying therapeutic pressure to the Yintang point.

    Other: Sham Light Touch

Interventions

  • OtherYintang Acupressure

    Manual pressure was applied to the Yintang point at 5-6 cm, 6-7 cm, and approximately 8 cm cervical dilation, during the third stage of labor, and at 60 minutes postpartum. Each session lasted approximately 6-7 minutes.

  • OtherSham Light Touch

    Light touch was applied at a non-therapeutic forehead location at the same assessment periods and for approximately the same duration as the experimental intervention, without therapeutic pressure at the Yintang point

06

What researchers measure

Primary outcomes

  1. Labor Pain Intensity

    Labor pain intensity was assessed using the Visual Analogue Scale (VAS), ranging from 0 to 100 mm. A score of 0 indicated no pain, and a score of 100 indicated the worst imaginable pain. Pain was assessed at prespecified stages during labor and at 60 minutes postpartum.

    Time frame: From enrollment at 5-6 cm cervical dilation through 60 minutes postpartum

Secondary outcomes

  1. Postpartum Anxiety

    Anxiety was assessed using the 21-item Beck Anxiety Inventory. Each item is scored from 0 to 3, producing a total score ranging from 0 to 63. Higher scores indicate greater anxiety.

    Time frame: At 60 minutes postpartum

07

Study locations

1 site
  • İnönü University
    Malatya, 44000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the informed consent obtained from participants did not include permission for public or third-party sharing of individual-level data. Aggregate study findings will be reported in scientific publications.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2024 to primary completion in Apr 2025, 10 months.

Of 191 non-industry interventional studies with no phase under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 14. This study's 10 months is above that.

Counting every sponsor, half of 193 studies reached it within 9 months; a quarter within 5 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2026
First posted
Aug 25, 2026
StartActual
Jun 1, 2024
Primary completionActual
Apr 30, 2025
CompletionActual
Dec 30, 2025
Last update
Aug 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07783776
Lead sponsor
Inonu University
Responsible party
Esra SABANCI BARANSEL (Assistant Professor, Inonu University) — Principal investigator
First posted
Aug 25, 2026
Start date
Jun 1, 2024
Primary completion
Apr 30, 2025
Completion
Dec 30, 2025
Last update
Aug 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion